VANCOUVER, BC / ACCESSWIRE / January 31, 2020 / EastWest Bioscience Inc. (TSXV:EAST) ("EastWest" or the "Corporation") announces that it filed its annual consolidated financial statements for the year ended July 31, 2019, related management discussion and analysis and applicable officer certificates (collectively, the "Annual Filings"). The Annual Filings can be accessed on the Company's SEDAR profile at www.sedar.com.

The Corporation has not yet filed its interim financial statements for the three month period ended October 31, 2019 (the "Quarter One Financial Statements"), the accompanying management's discussion and analysis and the related CEO and CFO certifications (the "Quarter One Filings"), which were due on December 30, 2019.

The Company provides this default status report in accordance with National Policy 12-203 – Cease Trade Orders for Continuous Disclosure Defaults ("NP 12-203"). In its initial default announcement of November 29, 2019 (the "Default Notice"), the Corporation announced the delay in the filing of its Annual Filings by the filing deadline of November 28, 2019. The Company subsequently provided bi-weekly default status reports on December 12, 2019, December 27, 2019, January 10, 2020, and January 23, 2020, in which it also announced that the Company anticipated that its interim financial statements for the three month period ended October 31, 2019 (the "Quarter One Financial Statements"), the accompanying management's discussion and analysis and the related CEO and CFO certifications (the "Quarter One filings"), which were due on December 31, 2019, would not be filed by the filing deadline, and would be filed after the Annual Filings were completed and filed.

As previously announced, the Corporation applied for and was granted management cease trade orders in respect of the delayed Annual Filings (the "MCTO") by the British Columbia Securities Commission and the Financial and Consumer Affairs Division of Saskatchewan which prohibit the chief financial officer and the chief executive officer from trading in the Corporation's securities for so long as there are filings that are outstanding under applicable securities laws. The MCTO does not affect the ability of the general investing public to trade in the Corporation's listed common shares.

The Corporation applied for and was granted an extension to the MCTO and to the filing deadline for the 2020 Quarter One Filings by the British Columbia Securities Commission, the principal regulator of the Corporation, to February 7, 2020. The Corporation has applied for the same extension from the Financial and Consumer Affairs Division of Saskatchewan, the response to which is pending.

The preparation of the Quarter One Financial Statements is progress and the Corporation expects to file the 2020 Quarter One Filings on or before February 7, 2020.

The Corporation confirms that since the Default Notice: (i) there is no material change to the information set out in the Default Notice that has not been generally disclosed; (ii) there has been no failure by the Corporation in fulfilling its stated intentions with respect to satisfying the provisions of the alternative information guidelines set out in NP 12-203; (iii) there has not been any other specified default by the Corporation under NP 12-203; and (iv) there is no other material information concerning the affairs of the Corporation that has not been generally disclosed.

The Corporation will continue to comply with the provisions of the alternative information guidelines under NP 12-203 by issuing bi-weekly default status reports in the form of news releases for so long as it remains in default of the filing requirements set out above.

ON BEHALF OF THE BOARD OF DIRECTORS
EASTWEST BIOSCIENCE GROUP

"Rodney Gelineau"
Chief Executive Officer and Director

"Paul Marjerrison"

Chief Financial Officer
TSXV – Symbol: EAST

Corporation Website: www.EastWestbioscience.com
Contact: Rodney Gelineau on 1-800-409-1930 or investors@EastWestscience.com.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to the terms and conditions of the Corporation's filing of annual financial statements for the fiscal year ended July 31, 2019, interim financial statements for the three months ended October 31, 2019, and the related management's discussion and analysis and the MCTO. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: management's perceptions of the anticipated timeline in which the Annual Filings and interim filings can be completed and filed, results of operations, operational matters, historical trends, current conditions and expected future developments, as well as other considerations that are believed to be appropriate in the circumstances. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: EastWest Bioscience Inc.

ReleaseID: 574897

SAN FRANCISCO, CA / ACCESSWIRE / January, 31, 2020 / Hagens Berman urges investors in Grand Canyon Education, Inc. (NASDAQ:LOPE) who have suffered significant losses to submit their losses now. The firm is actively investigating whether the Company and senior executives violated federal securities laws, and certain investors may have valuable claims.

Relevant Holding Period: Before Jan. 28, 2020

Sign Up: www.hbsslaw.com/investor-fraud/LOPE

Contact An Attorney Now: LOPE@hbsslaw.com

844-916-0895

Grand Canyon Education, Inc. (LOPE) Investigation:

The investigation centers on whether LOPE's financial reporting misled investors, including its accounting and disclosures with respect to related entities.

On Sept. 9, 2019, Citron Research published a report entitled, "Structural Change Without Legacy Customers Has (LOPE) Falling off a Cliff," accusing LOPE of moving costs to an off-balance sheet subsidiary to inflate the Company's profitability. This news drove the price of LOPE shares sharply lower that day.

Then, on Jan. 28, 2020, Citron published another scathing report about the Company entitled, "The Educational Enron; The Multiple Smoking Guns that Prove LOPE is Using a Captive Subsidiary to Manipulate Earnings." Likening LOPE to Enron, the research firm accused LOPE of "using Grand Canyon University as a liability dumping ground/cookie jar in order to manipulate earnings and cover up for the headwinds they face due to a challenging environment in for-profit online education." This news drove the price of LOPE shares sharply lower during intraday trading on Jan. 28, 2020.

"We're focused on investors' losses and whether LOPE secretly dumped costs on Grand Canyon to appear more profitable," said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you purchased shares of LOPE and suffered significant losses, click here to discuss your legal rights with Hagens Berman.

Whistleblowers: Persons with non-public information regarding LOPE should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email LOPE@hbsslaw.com.

# # #

About Hagens Berman
Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes is located at hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

CONTACT:

Reed Kathrein
844-916-0895

SOURCE: Hagens Berman Sobol Shapiro LLP

ReleaseID: 574896

This News Release is not for Distribution or Dissemination in the United States of America

TORONTO, ON / ACCESSWIRE / January 31, 2020 / GreenBank Capital Inc. (CSE:GBC)(OTCMKTS:GRNBF)(FRA:2TL) ("GreenBank or the Company") reports that it has obtained OSC approval for the revocation of a Cease Trade Order ("FFCTO") on its stock.

GreenBank was the subject of a FFCTO by the Ontario Securities Commission for failing to file the Company's financial statements, accompanying management's discussion and analysis, and the CEO and CFO certifications for the fiscal year ended July 31, 2018, in a timely manner. This was a consequence of the unexpected passing of the Founder Chairman and CEO, Daniel Wettreich. The management team has since re-built the institutional knowledge lost with the passing of the founder and met all its disclosure requirements.

GreenBank has filed an Undertaking that it will hold an Annual General Meeting within three months of the revocation of the FFCTO.

GreenBank will be filing an application to the Canadian Securities Exchange ("CSE") to resume trading of its common shares. Over the past year, GreenBank has focused on rebuilding lost institutional knowledge and streamlining its portfolio. The Company's future plans involve renewing its focus on merchant banking by nurturing select existing investments in its current portfolio, and exploring opportunities to make new investments that have the potential to build value for its shareholders.

About GreenBank

GreenBank is a merchant banking business listed on the Canadian Securities Exchange (trading symbols CSE: GBC and OTCMKTS: GRNBF and FRA: 2TL). GreenBank's 100% subsidiary GreenBank Financial Inc. is a merchant bank. GreenBank's portfolio companies comprise equity investments in 14 small cap businesses, namely; 52.5% of Blockchain Evolution Inc, owners of the world's first identification based blockchain, and developers of Xbook a user permissioned and revenue sharing social media platform; 22.6% of Ubique Minerals Limited, a zinc exploration company in Newfoundland, Canada; 47.7% of GBC Grand Exploration Inc, a gold exploration company in Newfoundland, Canada; 100% of Medik Blockchain Inc, providing blockchain based medical confidentiality systems to the healthcare community; 100% of Cannabis Blockchain Inc, developers of a digital information management system for the cannabis industry; 59.5% of Kabaddi Games Inc, developers of a mobile application game based on the sport of Kabaddi; 100% of North America Veterans Insurance Services Inc, an insurance agency holding company; 19% of Inside Bay Street Corporation, a financial news communications company; 34.8% of Gander Exploration Inc, a minerals exploration company in Newfoundland, Canada; 10% of Reliable Stock Transfer Inc, a Canadian small cap transfer agency; 25% of Buchans Wileys Exploration Inc, a minerals exploration company with interests in Newfoundland, Canada; 10% of The Lonsdale Group LLC, a USA based private equity company focused on small cap investments; 100% of Expatriate Assistance Services Inc, providing relocation services to expatriates; and 11.2% of Minfocus Exploration Corp (TSXV: MFX), a mineral exploration company.

For more information please see https://www.GreenBankCapitalinc.com or contact Mark Wettreich at (647) 693 9411 or by email mark@GreenBankCapitalinc.com

Forward-Looking Information: This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business and trading in the common stock of GreenBank Capital Inc., the raising of additional capital and the future development of the businesses comprising GreenBank's investment portfolio. The forward-looking information is based on certain key expectations and assumptions made by the company's management. Although the company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because GreenBank can give no assurance that they will prove to be correct. These forward-looking statements are made as of the date of this press release and GreenBank disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

SOURCE: GreenBank Capital Inc.

ReleaseID: 574895

NEW YORK, NY / ACCESSWIRE / January 31, 2020 / Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fiat Chrysler Automobiles N.V. (NYSE:FCAU) from February 26, 2016 to November 20, 2019, inclusive (the "Class Period") of the important January 31, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Fiat investors under the federal securities laws.

To join the Fiat class action, go to http://www.rosenlegal.com/cases-register-1732.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR'S ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Fiat employed a bribery scheme to obtain favorable terms in its collective bargaining agreement with International Union, United Automobile, Aerospace and Agricultural Implement Workers of America; (2) high-ranking Fiat officials were aware of and authorized the scheme; and (3) due to the foregoing, defendants' statements about Fiat's receivables, business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 31, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-register-1732.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or cases@rosenlegal.com.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has secured hundreds of millions of dollars for investors. Attorney advertising. Prior results do not guarantee a similar outcome.

——————————-

CONTACT:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

SOURCE: The Rosen Law Firm, P.A.

ReleaseID: 574894

NEW YORK, NY / ACCESSWIRE / January 31, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Exelon Corporation (NYSE:EXC)
Class Period: February 9, 2019 to November 1, 2019
Lead Plaintiff Deadline: February 14, 2020

The complaint alleges that throughout the class period Exelon Corporation made materially false and/or misleading statements and/or failed to disclose that: (i) Exelon and/or its employees were engaged in unlawful lobbying activities; (ii) the foregoing increased the risk of a criminal investigation into Exelon; (iii) Exelon subsidiary Commonwealth Edison's revenues were in part the product of unlawful conduct and thus unsustainable; and (iv) that, as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in EXC: http://www.kleinstocklaw.com/pslra-1/exelon-corporation-loss-submission-form?id=5394&from=1

Portola Pharmaceuticals, Inc. (NASDAQ:PTLA)
Class Period: November 5, 2019 to January 9, 2020
Lead Plaintiff Deadline: March 16, 2020

The PTLA lawsuit alleges that Portola Pharmaceuticals, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Portola's internal control over financial reporting regarding reserve for product returns was not effective; (2) Portola was shipping longer-dated product with 36-month shelf life; (3) Portola had not established adequate reserve for returns of prior shipments of short-dated product; (4) as a result, Portola was reasonably likely to need to "catch up" on accounting for return reserves; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in PTLA: http://www.kleinstocklaw.com/pslra-1/portola-pharmaceuticals-inc-loss-submission-form?id=5394&from=1

Geron Corporation (NASDAQ:GERN)
Class Period: March 19, 2018 to September 26, 2018
Lead Plaintiff Deadline: March 23, 2020

The filed complaint alleges that defendants misled investors regarding a drug called imetelstat, which was intended to treat certain cancers that occur in bone marrow. Specifically, defendants misled investors about the results of a clinical drug study of imetelstat called IMbark. That study was designed to ascertain whether imetelstat helped patients with a cancer called myelofibrosis.

Learn about your recoverable losses in GERN: http://www.kleinstocklaw.com/pslra-1/geron-corporation-et-al-loss-submission-form?id=5394&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

ReleaseID: 574893

LOS ANGELES, CA / ACCESSWIRE / January 31, 2020 / Andrew Waters, Executive Chairman of Florida-based company eCom Products Group Corporation (EPG) (OCTPINK:EPGC): announced today their agreement to acquire ELLESHOP China. Thanks to the efforts of Mr. Waters and CEO Jody Sigmund, the acquisition will be a smooth transition into EPG's already expansive social commerce services, sales channels, and cross-border portfolio.

China's leading online fashion portal linking brands and influencers, and engaging consumers to
transact.

As part of its continuing strategy to own several social commerce-based sales and service platforms, EPG, with operations in key strategic, high-growth markets, will acquire a controlling shareholding in Hearst Communication's ELLESHOP China. "We are commingling our media assets and increasing global brand reach for clients like Bloomingdale's looking to enter high-growth markets," said Sigmund.

Joint efforts are underway, with CEO Jack Wang of ELLE Shop China and CEO Jody Sigmund of EPG services to incorporate social commerce strategies and create a more organic engagement with China's sought-after KOLs (influencers). The merger will incorporate an in-house affiliate program to EPG's expansive eCommerce and cross-border offering. Brands will now access a full suite of services ranging from social influence management, online sales channels, destination marketing platforms, e-commerce, logistics and import/export services.

Mr. Waters stated, "The opportunity to acquire controlling interest in ELLE Shop China is an exciting addition to the sales channels and marketing platforms EPG offers our clients. The intended acquisition also strengthens our investor's portfolio."

ELLESHOP China is a growing fashion and lifestyle platform with strong brand positioning, key media channel partnerships, A-list celebrities, and high-profile influencers (KOLs). ELLE SHOP China's 15+ million consumer reach offers brands exclusive access entering China.

END

###

About eCom Products Group

"Simplifying brand success, from click to ship." For brands looking to enter high-growth markets, EPG simplifies market entry through social commerce, logistics, and a full suite of eCommerce service solutions.

CONTACT:
Michael Cox
eCom Products Group
michaelcox@helloepg.com

Related Files
EPG Acquires ELLE-20-1-28-Finance

MPG Intro 1080 V1

Related Images
elle-shop.jpg
ELLE Shop
China's leading online fashion portal linking brands and influencers, and engaging consumers to transact.

say-helloepg.jpg
Say helloEPG
EPG – "Simplifying brand success, from click to ship." For brands looking to enter high-growth markets, EPG simplifies market entry through social commerce, logistics, and
a full suite of eCommerce service solutions.

Related Links
EPG Services

Beauty Webinar

SOURCE: eCom Products Group

ReleaseID: 574823

LOS ANGELES, CA / ACCESSWIRE / January 31, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Facebook, Inc. ("Facebook" or "the Company") (NYSE:FB) for violations of the securities laws.

The investigation focuses on whether Facebook issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 574889

LOS ANGELES, CA / ACCESSWIRE / January 31, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of 500.com Limited ("500.com" or "the Company") (NYSE:WBAI) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. 500.com announced on December 31, 2019, that it would undertake an internal investigation into allegations of illegal money transfers. The investigation follows the arrest of one consultant to the Company (a former Director of the Company's Japanese subsidiary) along with two former consultants. The Company also announced the resignation of its Chairman of the Board and that its CEO would "step aside" for the duration of the investigation. Based on this news, shares of 500.com fell by more than 10% on January 2, 2020.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class in this case has not yet been certified, and until certification occurs you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 574886

LANGLEY, BC / ACCESSWIRE / January 31, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX) ("Adastra") is pleased to announce that as part of the corporation's long term incentive program, and pursuant to the terms and conditions of its stock option plan, the Adastra Board of Directors has approved the grant of 7,570,000 stock options to certain directors, officers, employees and consultants. The options expire five years from the date of grant, vest automatically upon grant, and are exercisable at a price of $0.45 per common share.

About Adastra Labs Holdings Ltd.

In Canada, Adastra is a British Columbia-based publicly traded cannabis company and, through its wholly owned subsidiaries, Adastra Labs Inc. and Chemia Analytics Inc., is in the application process to become a Standard Processor and is licensed as an Analytical Testing Laboratory under the Cannabis Act administered by Health Canada, with licences to produce cannabis extracts and provide third party analytical testing services. These licences will further enable Adastra and its subsidiaries to produce, package, sell (wholesale), and export medically focused and recreational cannabis extract and concentrate products in Canada to other licensed entities and internationally in jurisdictions where medical cannabis extraction products are legal.

www.adastralabs.ca

Andrew Hale
Chief Executive Officer
Adastra Labs Holdings Ltd.
Phone: (778) 715-5011
Email: andy@adastralabs.ca

Stephen Brohman
Chief Financial Officer
Adastra Labs Holdings Ltd.
Phone: (778) 715-5011
Email: steve@adastralabs.ca

Website: http://www.adastralabs.ca/
Address: 5451 275th Street, Langley, BC V4W 3X8
Telephone: 778-715-5011
Fax: 844-874-9893

CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION: This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate, among other things, to: Adastra's expectations concerning an increase in its production capacity. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political and social uncertainties. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Except as required by law, Adastra assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

SOURCE: Adastra Labs Holdings Ltd.

ReleaseID: 574868

VANCOUVER, BC and KNOXVILLE, TN / ACCESSWIRE / January 31, 2020 / Solar Alliance Energy Inc. ("Solar Alliance" or the "Company") (TSXV:SOLR)(OTC:SAENF) is pleased to announce the results of its Annual and Special General Meeting today. All resolutions were approved by shareholders, including:

(i) the shareholders voted in favour of appointing the nominees set forth in the Company's information circular of Jason Bak, Ken Stadlin, Anton Shihoff, Robert Miller and Michael Clark to serve as Directors of the Company for the ensuing year and to increase the number of directors to five;

(ii) Morgan & Company LLP was reappointed as auditors of the Company; and,

(iii) the Company's rolling 10% stock option plan was approved.

"I would like to thank shareholders for their continued support as we work to create a nationally-recognized brand that delivers benefits to the environment, customers and shareholders," said CEO Myke Clark. "The Solar Alliance team made significant progress in 2019 and the prospects for 2020 are exciting. We have reduced overhead at the corporate level to ensure resources are appropriately allocated to delivering new business and moving projects through the pipeline. We have also increased our focus on developing strategic partnerships that allow for expansion in a cost-effective manner, increasing profit margins on individual projects and driving towards overall company profitability."

The Company also announces that it has received TSX Venture Exchange approval to extend the expiry dates of three groups of share purchase warrants ("Warrants"): Group one is 2,783,333 outstanding Warrants with an original expiry date of February 28, 2020 that has been extended to February 28, 2022. Group two is 1,070,000 outstanding Warrants with an original expiry date of March 14, 2020 that has been extended to March 14, 2022. The third group is 11,121,265 outstanding Warrants with an expiry date of April 8, 2020 that has been extended to April 8, 2022. The exercise price on the Warrants will not change from $0.05. The Company has received approval and has issued a total of 2,233,333 common shares, at a price of $0.05 per share, to two companies controlled by officers of the Company as settlement of an aggregate of $111,666.65.

Myke Clark, CEO

For more information:

Solar Alliance Sales
(865) 309-4674

Solar Alliance
Myke Clark, CEO
604-288-9051
mclark@solaralliance.com

About Solar Alliance Energy Inc. (www.solaralliance.com)

Solar Alliance is an energy solutions provider focused on residential, commercial and industrial solar installations. The Company operates in California, Tennessee, North/South Carolina and Kentucky and has an expanding pipeline of solar projects. Since it was founded in 2003, the Company has developed $1 billion of wind and solar projects that provide enough electricity to power 150,000 homes. Our passion is improving life through ingenuity, simplicity and freedom of choice. Solar Alliance reduces or eliminates customers' vulnerability to rising energy costs, offers an environmentally-friendly source of electricity generation, and provides affordable, turnkey clean energy solutions.

Statements in this news release, other than purely historical information, including statements relating to the Company's future plans and objectives or expected results, constitute Forward-looking statements. The words "would", "will", "expected" and "estimated" or other similar words and phrases are intended to identify forward-looking information. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the Company's actual results, level of activity, performance or achievements to be materially different than those expressed or implied by such forward-looking information. Such factors include, but are not limited to: uncertainties related to the ability to raise sufficient capital, changes in economic conditions or financial markets, litigation, legislative or other judicial, regulatory and political competitive developments and technological or operational difficulties. Consequently, actual results may vary materially from those described in the forward-looking statements.

"Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release."

SOURCE: Solar Alliance Energy Inc.

ReleaseID: 574846